Neogen NEOG
$10.55 −$0.30 (-2.77%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.40 -1.42%
Open$10.76
Prev close$10.85
Day range$10.42 – $10.94
Volume3.04M
Market cap$2.30B
P/E (TTM)–
Dividend yield–
NEOG Stock News
Headlines matching Neogen or the NEOG ticker, most recent first.
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $14 Positive
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
- William Blair Maintains Neogen(NEOG.US) With Hold Rating
- Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
- Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13 Positive
- Piper Sandler Upgrades Neogen(NEOG.US) to Buy Rating, Raises Target Price to $14 Positive
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12
- Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
- Neogen Q1 Adj. EPS $0.08 Beats $(0.07) Estimate, Sales $222.800M Beat $208.175M Estimate Positive
- Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $12 Positive
- Neogen | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ranalli Tamara A.
- Neogen | 3: Initial statement of beneficial ownership of securities-Officer Ranalli Tamara A.
- Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Ranalli Tamara A.
No comments yet — be the first to weigh in on NEOG.
Sign in to join the discussion.